SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2014 / Cilt: 25 - Sayı: 6

Effects of mannose-binding lectin and mannose-binding lectin polymorphisms on treatment response in patients with chronic hepatitis C

SÜHEYLA KÖMÜR
AYŞE SEZA İNAL
Aslıhan Candevir ULU
Behice KURTARAN
Yeşim TAŞOVA
Hasan Salih Zeki AKSU
Pages
702–706
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, MBL levels were not found to have a significant effect on the course of the disease or treatment response.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: The natural course and clinical outcome of hepatitis C virus (HCV) infection is related to the interaction between HCV and the immune response of the host.
📊
Key Findings & Data:The aim of the present study was to explore the relationship between MBL levels and gene polymorphisms on treatment response in patients with chronic hepatitis C (CHC).Materials and Methods: Serum MBL levels from 50 CHC patients who completed treatment at least 24 weeks before the present study and 75 healthy HCV-negative controls were measured.
💡
Conclusion & Impact:Furthermore, MBL levels were not found to have a significant effect on the course of the disease or treatment response.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: The natural course and clinical outcome of hepatitis C virus (HCV) infection is related to the interaction between HCV and the immune response of the host. Only a limited number of studies have investigated the role of mannose-binding lectin (MBL) levels in HCV infection. The aim of the present study was to explore the relationship between MBL levels and gene polymorphisms on treatment response in patients with chronic hepatitis C (CHC).Materials and Methods: Serum MBL levels from 50 CHC patients who completed treatment at least 24 weeks before the present study and 75 healthy HCV-negative controls were measured. In addition, the presence of codon 54 mutations was investigated. Correlational analyses were performed to determine relationships between MBL levels and treatment response.Results: In patients, mean serum MBL levels were lower and the rate of codon 54 mutations was higher. However, these differences were not statically significant. In both patients and controls, serum MBL levels were significantly lower in individuals with codon 54 mutations. Moreover, serum MBL levels and the rate of the codon 54 mutation were similar in patients regardless of treatment response.Conclusion: Our findings suggest that low MBL levels do not increase the susceptibility for HCV infection. Furthermore, MBL levels were not found to have a significant effect on the course of the disease or treatment response.

🔖

Cite This Article

KÖMÜR, S., İNAL, A. S., ULU, A. C., KURTARAN, B., TAŞOVA, Y., AKSU, H. S. Z. (2014). Effects of mannose-binding lectin and mannose-binding lectin polymorphisms on treatment response in patients with chronic hepatitis C. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 6, 702–706. https://ajindex.com/articles/410763

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Thomas DL, Ray SC, Lemon SM. Hepatitis C. In Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th Ed. Philadelphia: Elsevier Churchill Livingstone; 2005.p.1950-81
  2. Ghany MC, Strader DB, Thomas DL, et al. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2009; 49: 1335-74
  3. Eisen DP, Minchinton RB. Impact of mannose-binding on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496-505
  4. Matsushita M, Hijikata M, Ohta Y, et al. Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch Virol 1998; 143: 645-51
  5. Matsushita M, Hijikata M, Ohta Y, et al. Association of mannosebinding lectin gene haplotype LXPA and LYPB with interferonresistant hepatitis C virus in Japanese patients. J Hepatol 1998; 29: 695-700
  6. Brown KS, Ryder SD, Irving WL, et al. Mannan binding lectin and viral hepatitis. Immunol Lett 2007; 108: 34-44
  7. Wang H, Nakamura K, Inone T, et al. Mannose binding polymorphisms in patients with Behçet's disease. J Derm Sci 2004; 36: 115-17
  8. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38: 133-49
  9. Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev 2005; 4: 364-72
  10. Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin a soluble pattern recogition molecule. Mol Immunol 2004; 41: 113-21
  11. Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 2006; 43: 86-96
  12. Dumestre-Perard C, Doerr E, Colomb MG, et al. Involment of complement pathways in patients with bacterial septicemia. Mol Immunol 2007; 44: 1631-8
  13. Jüliger S, Kremsner PG, Alpers MP, et al. Restricted polymorphisms of the mannose-binding lectin gene in a Population of Papua New Guinea. Mutat Res 2002; 505: 87-91
  14. Babula O, Lazdane G, Kroica J, et al. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannosebinding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003; 37: 733-7
  15. Thomas HC, Foster GR, Sumiya M, et al. Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 1996; 348: 1417-9
  16. Özbaş-Gerçeker F, Tezcan İ, Berkel Aİ, et al. The effect of mannosebinding protein gene polymorphisms in recurrent respirator